Published in J Mol Biol on September 30, 2005
Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J Phys Chem B (2008) 4.68
Effects of magnesium and related divalent metal ions in topoisomerase structure and function. Nucleic Acids Res (2009) 1.32
Molecular dynamics simulations of the dynamic and energetic properties of alkali and halide ions using water-model-specific ion parameters. J Phys Chem B (2009) 1.25
Solution structures of DNA-bound gyrase. Nucleic Acids Res (2010) 0.90
Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB. Antimicrob Agents Chemother (2009) 0.86
Metal ion and inter-domain interactions as functional networks in E. coli topoisomerase I. Gene (2013) 0.78
Potassium ions are required for nucleotide-induced closure of gyrase N-gate. J Biol Chem (2012) 0.78
Human-mouse genome comparisons to locate regulatory sites. Nat Genet (2000) 8.08
DNA gyrase: structure and function. Crit Rev Biochem Mol Biol (1991) 5.25
Crystal structure of the breakage-reunion domain of DNA gyrase. Nature (1997) 4.10
Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature (1991) 3.93
A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob Agents Chemother (1993) 3.43
Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins. Antimicrob Agents Chemother (1991) 2.82
The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry (1993) 2.79
The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography. EMBO J (1996) 2.60
Tryptic fragments of the Escherichia coli DNA gyrase A protein. J Biol Chem (1989) 2.56
The DNA dependence of the ATPase activity of DNA gyrase. J Biol Chem (1984) 2.51
Mechanistic aspects of DNA topoisomerases. Adv Protein Chem (1986) 2.35
gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase. Mol Microbiol (1992) 2.19
Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87). Antimicrob Agents Chemother (2001) 1.76
A model for the mechanism of strand passage by DNA gyrase. Proc Natl Acad Sci U S A (1999) 1.74
The C-terminal domain of the Escherichia coli DNA gyrase A subunit is a DNA-binding protein. Nucleic Acids Res (1991) 1.74
The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition. J Mol Biol (2001) 1.74
Conversion of DNA gyrase into a conventional type II topoisomerase. Proc Natl Acad Sci U S A (1996) 1.70
Cloning of the DNA gyrase genes under tac promoter control: overproduction of the gyrase A and B proteins. Gene (1990) 1.65
B protein of bacteriophage mu is an ATPase that preferentially stimulates intermolecular DNA strand transfer. Proc Natl Acad Sci U S A (1987) 1.64
Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab (1998) 1.63
Validation of a technique for studying functional adaptation of the mouse ulna in response to mechanical loading. Bone (2002) 1.59
The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex. J Mol Biol (2000) 1.50
Structure of the DNA gyrase-DNA complex as revealed by transient electric dichroism. J Mol Biol (1987) 1.47
Identifying the catalytic residue of the ATPase reaction of DNA gyrase. Proc Natl Acad Sci U S A (1993) 1.44
DNA gyrase can supercoil DNA circles as small as 174 base pairs. EMBO J (1989) 1.44
The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J Mol Biol (1994) 1.40
A comparison of adhesives useable in the cold for the preparation of cryostat sections. Stain Technol (1971) 1.39
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer. Eur J Cancer (1993) 1.38
DNA supercoiling by DNA gyrase. A static head analysis. Cell Biophys (1988) 1.37
Probing the limits of the DNA breakage-reunion domain of the Escherichia coli DNA gyrase A protein. J Biol Chem (1991) 1.36
Neutron and light-scattering studies of DNA gyrase and its complex with DNA. J Mol Biol (1990) 1.35
Probing the binding of coumarins and cyclothialidines to DNA gyrase. Biochemistry (1999) 1.32
DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex. Biochemistry (1996) 1.31
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. J Med Chem (1996) 1.29
Psychosocial interest, medical interviews, and the recognition of depression. Arch Fam Med (1994) 1.28
Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting. Nucleic Acids Res (1994) 1.27
Escherichia coli cells resistant to the DNA gyrase inhibitor, ciprofloxacin, overproduce a 60 kD protein homologous to GroEL. Mol Microbiol (1990) 1.27
The interaction of coumarin antibiotics with fragments of DNA gyrase B protein. Biochemistry (1996) 1.27
Corynebacterium endophthalmitis. Laboratory studies and report of a case treated by vitrectomy. Arch Ophthalmol (1979) 1.25
The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage. J Biol Chem (1998) 1.23
In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites. Proc Natl Acad Sci U S A (2001) 1.23
Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase. Nucleic Acids Res (1996) 1.18
Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein. Biochemistry (1995) 1.16
The SalGI restriction endonuclease. Mechanism of DNA cleavage. Biochem J (1982) 1.14
The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription. J Mol Biol (1997) 1.12
Probing the two-gate mechanism of DNA gyrase using cysteine cross-linking. Biochemistry (1999) 1.12
The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action. Nucleosides Nucleotides Nucleic Acids (2000) 1.10
Quinolone binding to DNA is mediated by magnesium ions. Proc Natl Acad Sci U S A (1992) 1.10
Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol (2012) 1.09
The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs. Mol Microbiol (1994) 1.08
Growth charts, growth velocity and bone development in childhood obesity. Int J Obes Relat Metab Disord (1995) 1.06
Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase. J Antibiot (Tokyo) (1993) 1.06
6-Aminoquinolones as new potential anti-HIV agents. J Med Chem (2000) 1.05
Patient presentation, interview content, and the detection of depression by primary care physicians. Psychosom Med (1994) 1.04
The effect of the minor groove binding agent DAPI (4,6-diamidino-2-phenyl-indole) on DNA-directed enzymes: an attempt to explain inhibition of plasmid expression in Escherichia coli [corrected]. FEMS Microbiol Lett (1990) 1.03
The cleavage of DNA at phosphorothioate internucleotidic linkages by DNA gyrase. Nucleic Acids Res (1992) 1.03
The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the existence of two gyrase-CcdB complexes. J Mol Biol (1999) 1.03
Conformational changes in DNA gyrase revealed by limited proteolysis. J Biol Chem (1998) 1.02
Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential. Curr Med Chem (2009) 1.02
Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage. J Mol Biol (2001) 1.02
gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity. J Mol Biol (2001) 1.02
Scattered radiation during fixation of hip fractures. Is distance alone enough protection? J Bone Joint Surg Br (2001) 1.01
Crystallization of inhibitor complexes of an N-terminal 24 kDa fragment of the DNA gyrase B protein. J Mol Biol (1994) 0.99
The additional 165 amino acids in the B protein of Escherichia coli DNA gyrase have an important role in DNA binding. J Biol Chem (2000) 0.97
The SalGI restriction endonuclease. Enzyme specificity. Biochem J (1982) 0.96
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Cancer Res (2001) 0.96
The SalGI restriction endonuclease. Purification and properties. Biochem J (1982) 0.96
Pyrrolo-quinoline derivatives as potential antineoplastic drugs. Bioorg Med Chem (2000) 0.95
Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions. J Mol Biol (2001) 0.94
Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab (2001) 0.94
Quality of life in shift work syndrome. Funct Neurol (1997) 0.94
Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase. Biochemistry (1998) 0.94
Locking the DNA gate of DNA gyrase: investigating the effects on DNA cleavage and ATP hydrolysis. Biochemistry (1999) 0.93
Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome. Minerva Ginecol (2014) 0.92
Do quinolones bind to DNA? Biochem Pharmacol (1988) 0.92
Solid-state infrared absorption spectra and chain arrangement in some synthetic homooligopeptides in the intermolecularly hydrogen-bonded pleated-sheet beta-conformation. Biopolymers (1977) 0.91
Kinetic studies on the removal of iron and aluminum from recombinant and site-directed mutant N-lobe half transferrins. Biochemistry (1998) 0.91
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci (2011) 0.91
Sequence specificity of psoralen photobinding to DNA: a quantitative approach. Biochemistry (1992) 0.90
Unexplained infertility and ovulatory induction with menopausal gonadotropins. Minerva Ginecol (2014) 0.90
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. Mol Pharmacol (1995) 0.90
The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage. Nucleic Acids Res (2001) 0.90
The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Health Technol Assess (2011) 0.90
Hydrolysis of ATP at only one GyrB subunit is sufficient to promote supercoiling by DNA gyrase. J Biol Chem (1998) 0.90
Novel pyrrolo[3,2-f]quinolines: synthesis and antiproliferative activity. Bioorg Med Chem (2001) 0.90
Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project. Clin Radiol (2010) 0.89
Ovulation induction with clomiphene citrate for infertile couple. Minerva Ginecol (2014) 0.89
Irreversible and reversible topoisomerase II DNA cleavage stimulated by clerocidin: sequence specificity and structural drug determinants. Cancer Res (1997) 0.89
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol (2005) 0.89
Energy coupling in DNA gyrase: a thermodynamic limit to the extent of DNA supercoiling. Biochemistry (1992) 0.88
Dinuclear Zn(2+) complexes of synthetic heptapeptides as artificial nucleases. J Am Chem Soc (2001) 0.88
Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage. J Mol Biol (1994) 0.88
Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sci (2003) 0.87
Circle size discrimination and transposition behaviour in cichlid fish. Anim Behav (1969) 0.87
Preliminary crystallographic analysis of the ATP-hydrolysing domain of the Escherichia coli DNA gyrase B protein. J Mol Biol (1991) 0.87
On the oxy analogues to the 4 leads to 1 intramolecularly hydrogen-bonded peptide conformations. Macromolecules (1976) 0.87
Muscle power after surgery. Lancet (1980) 0.86
Liquid-crystalline structure of nucleic acids: effect of antracycline drugs and copper ions. J Biomol Struct Dyn (1997) 0.86